Mallika Singh
6Patents
4h-index
34Co-inventors
53Inventor score
Filing activity: Sep 10, 2008 → Nov 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8604014B2 | Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use | Emerging Cross-Sectional Technologies | 25 | Active |
| US8247397B2 | Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use | Emerging Cross-Sectional Technologies | 24 | Active |
| US11690915B2 | Ras inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10364466B2 | Biological markers for identifying patients for treatment with VEGF antagonists | Physics | 6 | Active |
| US11596633B2 | SHP2 inhibitor compositions and methods for treating cancer | Human Necessities | 0 | Active |
| US12121522B2 | Methods of treating cancer with an mTOR inhibitor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.